Cohen Lawrence B Ac Immune Sa Transaction History

Cohen Lawrence B

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 03, 2020	SELL	$4.78 - $9.06 $2,390 - $4,530	-500 Reduced 3.75%	12,850 $63,000
Q4 2018 Jan 14, 2019	SELL	$7.35 - $11.7 $11,025 - $17,550	-1,500 Reduced 10.1%	13,350 $126,000
Q3 2018 Oct 23, 2018	SELL	$7.88 - $16.45 $44,916 - $93,765	-5,700 Reduced 27.74%	14,850 $119,000
Q1 2018 Apr 19, 2018	BUY	$10.34 - $13.78 $77,550 - $103,350	7,500 Added 57.47%	20,550 $212,000
Q3 2017 Nov 03, 2017	BUY	$7.06 - $11.2 $92,133 - $146,160	13,050	13,050 $146,000

27.9M

150K

12.4K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $218M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Cohen Lawrence B, based on Form 13F filings with the SEC.

Stay updated on Cohen Lawrence B with notifications on news.